Menu Back toSession-9-Protecting-Confidential-Information-in-Summaries-of-Trial-Results

Global Clinical Trial Disclosure and Data Transparency Conference

Learn about the latest global requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.

Session 9: Protecting Confidential Information in Summaries of Trial Results

Session Chair(s)

Robert  Paarlberg, MS

Robert Paarlberg, MS

  • Principal
  • Paarlberg & Associates LLC, United States
Global clinical data disclosure and transparency requirements and initiatives have resulted in massive amounts of clinical data in the public domain. Local county and regional data protection regulations safe guard personal identifiable information from public disclosure. This session will explore how patient identifiable data are being protected in this global clinical disclosure/transparency ecosystem.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Discuss the interplay between disclosure/transparency requirements and country/regional data protection regulations
  • Identify stakeholder perspectives
  • Implement best practices


Behtash  Bahador, MS

Protecting Confidentiality: Public and Patient Perceptions and Best Communication Practice

Behtash Bahador, MS

  • Associate Director, Relationship Management and Development
  • Center for Information and Study on Clinical Research Participation (CISCRP), United States
Michael A. DiMaio, JD

Common Challenges Under GDPR for Data Disclosure and Transparency

Michael A. DiMaio, JD

  • Attorney
  • Ropes & Gray LLP, United States
Brendan  Barnes

Anonymisation and Public Trust (Remote Presentation)

Brendan Barnes

  • Director, Data Protection & IP
  • EFPIA, Belgium